Delcath Systems, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Rosalind Advisors and its affiliates updated their beneficial ownership in Delcath Systems, Inc., maintaining a 9.9% stake and confirming board appointments.
NASDAQ
SCHEDULE 13D/A: Rosalind Advisors and Affiliates Maintain Significant Stake in Delcath Systems, Appointing Key Directors
An amendment to a Schedule 13D filing reveals Rosalind Advisors and its affiliated funds continue to hold a substantial beneficial ownership in Delcath Systems, with key personnel Steven Salamon and Gil Aharon serving as independent directors on the company's board.
NASDAQ
SCHEDULE 13D/A: Rosalind Advisors and Affiliates Maintain Significant Stake in Delcath Systems, Directors' Appointments Confirmed
Rosalind Advisors, along with its affiliated funds and principals, filed an amended Schedule 13D disclosing their continued beneficial ownership of approximately 9.9% of Delcath Systems, Inc. common shares, while also confirming the 2020 appointments of Steven Salamon and Gilad Aharon to the company's Board of Directors.